Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-Mediated JAK2/STAT5 signalling pathway in the TF-1/ Epo human leukemia cell line

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2453-2459

  Li, Jing ^a   Wei, Qiang ^a   Zuo, Guo Wei ^b   Xia, Jing ^a   You, Zhi Mei ^a   Li, Chun Li ^c   Chen, Di Long ^a  

^a Department of Histology and Embryology   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Erythropoietin receptor; Ginsenoside Rg1; Jak2; Leukemia; Stat5

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GINSENOSIDE; GINSENOSIDE RG 1; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; MESSENGER RNA; STAT5 PROTEIN;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; HUMAN; LEUKEMIA; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM AGENTS; ERYTHROPOIETIN; GINSENOSIDES; HUMANS; JANUS KINASE 2; LEUKEMIA; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ERYTHROPOIETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED;

EID: 84899790223     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2453     Document Type: Article

References (25)

1. Chen D, Zuo G, Li C, et al. (2009). Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2/STAT5 signaling pathway. J Ethnopharmacol, 126, 215-20.
2. Gao Y, Deng J, Yu X-F, et al. (2011). Ginsenoside Rg1 inhibits vascular intimal hyperplasia in balloon-injured rat carotid artery by down-regulation of extracellular signal-regulated kinase 2. J Ethnopharmacol, 138, 472-8.
3. Kilpivaara O, and Levine R. (2008). JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukemia, 22, 1813-7.
4. Kitamura T, Tange T, Terasawa T, et al. (1989). Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol, 140, 323-34.
5. Kumar S M, Zhang G, Bastian B C, et al. (2011). Erythropoietin receptor contributes to melanoma cell survival in vivo. Oncogene, 31, 1649-60.
6. Lee H J, Daver N, Kantarjian H M, et al. (2013). The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia. Clin Cancer Res, 19, 327-35.
7. Li Q-F, Shi S-L, Liu Q-R, et al. (2008). Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin. Int J Biochem Cell Biol, 40, 1918-29.
8. Liu J, Cai S-Z, Zhou Y, et al. (2012). Senescence as a consequence of ginsenoside rg1 response on k562 human leukemia cell Line. Asian Pac J Cancer Prev, 13, 6191-6.
9. Lord J D, McIntosh B C, Greenberg P D, et al. (2000). The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol, 164, 2533-41.
10. Ma Z-c, Gao Y, Wang Y-g, et al. (2006). Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-α. Acta Pharmacol Sin, 27, 1000-6.
11. O'Shea J J, Gadina M, and Schreiber R D. (2002). Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell, 109, 121-31.
12. Pelletier S, Gingras S, Funakoshi-Tago M, et al. (2006). Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function. Mol Cell Biol, 26, 8527-38.
13. Raghavendran H R B, Sathyanath R, Shin J, et al. (2012). Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: ginsenoside Rg1 partially supports myelopoiesis. PloS one, 7, 33733.
14. Salomons G S, Brady H J, Verwijs-Jansen M, et al. (1997). The Baxalfa: Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukemia. Int J Cancer, 71, 959-65.
15. Santos F P, and Verstovsek S. (2011). JAK2 inhibitors: What's the true therapeutic potential? Blood reviews, 25, 53-63.
16. Shi S L, Li Q F, Liu Q R, et al. (2009). Nuclear matrix protein, prohibitin, was down regulated and translocated from nucleus to cytoplasm during the differentiation of osteosarcoma MG-63 cells induced by ginsenoside Rg1, cinnamic acid, and tanshinone IIA (RCT). J Cell Biochem, 108, 926-34.
17. Tam W F, Hahnel P S, Schuler A, et al. (2013). STAT5 Is Crucial to Maintain Leukemic Stem Cells in Acute Myelogenous Leukemias Induced by MOZ-TIF2. Cancer Res, 73, 373-84.
18. Verdier F, Walrafen P, Hubert N, et al. (2000). Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors. J Biol Chem, 275, 18375-81.
19. Walz C, Cross N C, Van Etten et al. (2008). Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders. Leukemia, 22, 1320-34.
20. Wang C-Z, Aung H H, Ni M, et al. (2007). Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med, 73, 669.
21. Wang Y, Ye X, Ma Z, et al. (2008). Induction of cytochrome P450 1A1 expression by ginsenoside Rg1 and Rb1 in HepG2 cells. Eur J Pharmacol, 601, 73-8.
22. Warsch W, Walz C, Sexl V. (2013). JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia. Blood, 122, 2167-75.
23. Wu P, Zhang N, Wang X, et al. (2012). The erythropoietin/ erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells. PloS one, 7, 45122.
24. Zamzami N, Brenner C, Marzo I, et al. (1998). Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene, 16, 2265-82.
25. Zuo G, Guan T, Chen D, et al. (2009). Total saponins of Panax ginseng induces K562 cell differentiation by promoting internalization of the erythropoietin receptor. Am J Chin Med, 37, 747-57.